Year: 2026
Type: article
Abstract: Granulocyte colony-stimulating factor is a hematopoietic cytokine mainly produced by myeloid cells. Its primary role is to stimulate and promote neutrophil proliferation, which is commonly used in oncology to prevent myelosuppression often caused by cytotoxic treatment. Growing evidence suggests that its biological activity may extend beyond hematopoiesis and modulate tumor dynamics. Several studies indicate that elevated G-CSF levels and receptor expression are associated with greater aggressiveness and a more unfavourable prognosis. The role of G-CSF in fostering an immunosuppressive microenvironment, supporting metastasis, and promoting tumor growth has become a common area of research. Furthermore, studies have already claimed a higher incidence of secondary malignancies, like acute myeloid leukemia (AML) and myelodysplastic syndrome, among patients receiving G-CSF along with cytotoxic treatment.
Source: Quality in Sport
Authors: Barbara Pietrzak, Mikołaj Patelski, Adrianna Klimczak, Wiktoria Kotlarz, Marta Kamińska, Matylda Kuczma, Jakub Molenda, Maciej Czapla, Mateusz Surma, Wiktoria Mikusek
Institution: Poznan University of Medical Sciences
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7155705343
FWCI:
Cites:
Cited by:
Related to: